Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Johnson and Johnson
Daiichi Sankyo
Boehringer Ingelheim
Baxter

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 9,029,510

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,029,510
Title:Fully human antibodies that bind to VEGFR2 and methods of use thereof
Abstract: There is disclosed compositions and methods relating to anti-VEGFR2 antibodies. More specifically, there is disclosed fully human antibodies that bind VEGFR2, VEGFR2-binding fragments and derivatives of such antibodies, and VEGFR2-binding polypeptides comprising such fragments. Further still, there is disclosed antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having various cancers.
Inventor(s): Gastwirt; Randy (San Diego, CA), Zhou; Heyue (San Diego, CA), Gray; John Dixon (San Diego, CA), Lu; Guodi (San Diego, CA)
Assignee: Sorrento Therapeutics, Inc. (San Diego, CA)
Application Number:13/854,071
Patent Claims:see list of patent claims

Details for Patent 9,029,510

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up Sorrento Therapeutics, Inc. (San Diego, CA) 2036-04-30 RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Sorrento Therapeutics, Inc. (San Diego, CA) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,029,510

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2013149219 Nov 21, 2013
World Intellectual Property Organization (WIPO) 2013149219 Oct 03, 2013
United States of America 2014294827 Oct 02, 2014
United States of America 2017166644 Jun 15, 2017
United States of America 2019048087 Feb 14, 2019
Hong Kong 1206610 Jan 15, 2016
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Mallinckrodt
QuintilesIMS
UBS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.